US loss of exclusivity · Oncology

Darzalex

Johnson & Johnson

2029US biosimilars from
2025Today: 20262037
2025 worldwide sales
$14.3B
Date basis
Patent-expiry estimate
US biosimilars
In clinical trials
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Darzalex timeline →